The status of paediatric medicines initiatives around the world—what has happened and what has not?

被引：0

作者：

Kalle Hoppu

Gabriel Anabwani

Facundo Garcia-Bournissen

Madlen Gazarian

Gregory L. Kearns

Hidefumi Nakamura

Robert G. Peterson

Shalini Sri Ranganathan

Saskia N. de Wildt

机构：

[1] University of Helsinki and Poison Information Centre,Hospital for Children and Adolescents and Dept. of Clinical Pharmacology

[2] Helsinki University Central Hospital,Paediatric Therapeutics Program, School of Women’s and Children’s Health

[3] Botswana-Baylor Children’s Clinical Centre of Excellence,School of Medical Sciences, Faculty of Medicine

[4] Buenos Aires Children’s Hospital “R Gutierrez”,Departments of Pediatrics and Pharmacology

[5] University of New South Wales and Sydney Children’s Hospital,Division of Pediatric Pharmacology and Medical Toxicology

[6] Randwick,Division for Clinical Trials, Clinical Research Center

[7] University of New South Wales,Department of Pediatrics, Faculty of Medicine

[8] University of Missouri,Department of Pharmacology, Faculty of Medicine

[9] The Children’s Mercy Hospital,Intensive Care and Pediatric Surgery

[10] National Center for Child Health and Development,undefined

[11] University of British Columbia,undefined

[12] University of Colombo,undefined

[13] Erasmus MC,undefined

[14] Sophia Children’s Hospital,undefined

来源：

European Journal of Clinical Pharmacology | 2012年 / 68卷

关键词：

Biomedical research; Legislation; Jurisprudence; Child; Drugs, investigational;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1 / 10

页数：9

共 50 条